Browsing by Author "Zimarino, Marco (57215992419)"
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Antithrombotic therapy after percutaneous coronary intervention of bifurcation lesions(2021) ;Zimarino, Marco (57215992419) ;Angiolillo, Dominick J. (6701541904) ;Dangas, George (7006593805) ;Capodanno, Davide (25642544700) ;Barbato, Emanuele (58118036500) ;Hahn, Joo-Yong (12771661800) ;Giustino, Gennaro (55964550000) ;Watanabe, Hirotoshi (55624475534) ;Costa, Francesco (57203815908) ;Cuisset, Thomas (14627332500) ;Rossini, Roberta (6603679502) ;Sibbing, Dirk (10041326200) ;Burzotta, Francesco (7003405739) ;Louvard, Yves (7004523655) ;Shehab, Abdulla (6603838351) ;Renda, Giulia (6701747626) ;Kimura, Takeshi (26643375000) ;Gwon, Hyeon-Cheol (6603262426) ;Chen, Shao-Liang (35186717200) ;Costa, Ricardo (7203063525) ;Koo, Bon-Kwon (35285769200) ;Storey, Robert F. (7101733693) ;Valgimigli, Marco (57222377628) ;Mehran, Roxana (7004992409)Stankovic, Goran (59150945500)Coronary bifurcations exhibit localised turbulent flow and an enhanced propensity for atherothrombosis, platelet deposition and plaque rupture. Percutaneous coronary intervention (PCI) of bifurcation lesions is associated with an increased risk of thrombotic events. Such risk is modulated by anatomical complexity, intraprocedural factors and pharmacological therapy. There is no consensus on the appropriate PCI strategy or the optimal regimen and duration of antithrombotic treatment in order to decrease the risk of ischaemic and bleeding complications in the setting of coronary bifurcation. A uniform therapeutic approach meets a clinical need. The present initiative, promoted by the European Bifurcation Club (EBC), involves opinion leaders from Europe, America, and Asia with the aim of analysing the currently available evidence. Although mainly derived from small dedicated studies, substudies of large trials or from authors' opinions, an algorithm for the optimal management of patients undergoing bifurcation PCI, developed on the basis of clinical presentation, bleeding risk, and intraprocedural strategy, is proposed here. © Europa Digital & Publishing 2021. All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication Percutaneous coronary intervention for bifurcation coronary lesions: The 15th consensus document from the European Bifurcation Club(2021) ;Burzotta, Francesco (7003405739) ;Lassen, Jens Flensted (57189389659) ;Lefèvre, Thierry (13608617100) ;Banning, Adrian P. (57957647700) ;Chatzizisis, Yiannis S. (13907765800) ;Johnson, Thomas W. (56418917800) ;Ferenc, Miroslaw (8933716300) ;Rathore, Sudhir (22235271400) ;Albiero, Remo (7003819431) ;Pan, Manuel (7202544866) ;Darremont, Olivier (23666794700) ;Hildick-Smith, David (8089365300) ;Chieffo, Alaide (57202041611) ;Zimarino, Marco (57215992419) ;Louvard, Yves (7004523655)Stankovic, Goran (59150945500)The 15th European Bifurcation Club (EBC) meeting was held in Barcelona in October 2019. It facilitated a renewed consensus on coronary bifurcation lesions (CBL) and unprotected left main (LM) percutaneous interventions. Bifurcation stenting techniques continue to be refined, developed and tested. It remains evident that a provisional approach with optional side branch treatment utilising T, T and small protrusion (TAP) or culotte continues to provide flexible options for the majority of CBL patients. Debate persists regarding the optimal treatment of side branches, including assessment of clinical significance and thresholds for bail-out treatment. In more complex CBL, especially those involving the LM, adoption of dedicated two-stent techniques should be considered. Operators using such techniques have to be fully familiar with their procedural steps and should acknowledge associated limitations and challenges. When using two-stent techniques, failure to perform a final kissing inflation is regarded as a technical failure, since it may jeopardise clinical outcome. The development of novel technical tools and drug regimens deserves attention. In particular, intracoronary imaging, bifurcation simulation, drug-eluting balloon technology and tailored antiplatelet therapy have been identified as promising tools to enhance clinical outcomes. In conclusion, the evolution of a broad spectrum of bifurcation PCI components has resulted from studies extending from bench testing to randomised controlled trials. However, further advances are still needed to achieve the ambitious goal of optimising the clinical outcomes for every patient undergoing PCI on a CBL. © Europa Digital & Publishing 2021.
